Search

everythinglearnresearchcommunity

for

Search:↓

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Lupus can cause hair loss and nail changes, with treatments available for both.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

More research is needed to understand alopecia areata severity.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Scalp involvement in pemphigus means the disease is more severe and harder to treat.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

Lupus pneumonitis can be misdiagnosed as pneumonia or tuberculosis, so consider lupus in similar cases for proper treatment.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.